首页>
外国专利>
LKB1/STK11 DELETION IN MELANOMA AND RELATED METHODS
LKB1/STK11 DELETION IN MELANOMA AND RELATED METHODS
展开▼
机译:LKB1 / STK11在黑色素瘤中的切除及相关方法
展开▼
页面导航
摘要
著录项
相似文献
摘要
LKB1 mutation status and/or expression, YES expression and phosphorylation level; and/or CD24 expression are employed to predict melanoma prognosis and response to therapeutics. Inhibitors (including targeted inhibitors) of SRC family kinases (especially YES) are employed to treat melanoma.
展开▼